MISRA TUSHAR (Chief Manufacturing Officer) sold 14.2% of their position (1.91K shares) of MERSANA THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/18/2023ACC: 0001104659-23-093468
Officer· Chief Manufacturing Officer
Since Aug 2021
-1.91K
Net shares
Net seller
$2.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.25K acquired · 8.16K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.25K
Price / share
—
Trade value
—
% of position
87.2%
8/16/2023
7.17K→13.41K
Common Stock
Direct
Shares
−1.91K
Price / share
$1.18
Trade value
$2.25K
% of position
14.2%
8/17/2023
13.41K→11.51K
Total
Net shares
+4.34K
Net value
-$2.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/16/2023 | M · Option Exercise | +6.25K | — | — | 87.2% | 7.17K | 13.41K |
| Common Stock Direct | 8/17/2023 | S · Sale | −1.91K | $1.18 | $2.25K | 14.2% | 13.41K | 11.51K |
| Total | +4.34K | -$2.25K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
6.25K shares
Shares
−6.25K
Strike price
Held after
12.50K
Exercisable
—
8/16/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock6.25K shares | 8/16/2023 | M · Option Exercise | −6.25K | — | 12.50K |